ZFAS1 and hepatocellular carcinoma: In resistant HCC models, PERK/ATF4-dependent ZFAS1 upregulation correlates with ER stress activation, while pharmacological PERK inhibition restores drug sensitivity by suppressing ZFAS1 expression [90] (Fig. 3A).